APA (7th ed.) Citation

Gelhorn, H. L., Osumili, B., Brown, K., Ross, M. M., Schulz, A., Fernandez, G., & Boye, K. S. (2023). The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes. Patient Preference & Adherence, 17, 793. https://doi.org/10.2147/PPA.S401465

Chicago Style (17th ed.) Citation

Gelhorn, Heather L., Beatrice Osumili, Katelyn Brown, Melissa M. Ross, Andrea Schulz, Gabriela Fernandez, and Kristina S. Boye. "The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes." Patient Preference & Adherence 17 (2023): 793. https://doi.org/10.2147/PPA.S401465.

MLA (9th ed.) Citation

Gelhorn, Heather L., et al. "The Impact of Substantial Improvements in HbA1c and Weight Loss on the Medication Preferences of People with Type 2 Diabetes." Patient Preference & Adherence, vol. 17, 2023, p. 793, https://doi.org/10.2147/PPA.S401465.